-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Apellis Pharmaceuticals, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2018 to Q1 2024.
- Apellis Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$133M, a 25.1% increase year-over-year.
- Apellis Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$87.9M, a 85.2% increase from 2023.
- Apellis Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$595M, a 15.8% decline from 2022.
- Apellis Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$514M, a 8.77% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)